Dr. Reddy’s Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of Bridion®, in the United State
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| DR. REDDY'S LAB LTD ADR (NYSE: RDY) | Delayed: 13.25 +0.06 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.19 | 52 Week High | $54.73 | |||
| Open | $13.11 | 52 Week Low | $40.68 | |||
| Day High | $13.29 | P/E | N/A | |||
| Day Low | $13.06 | EPS | $0.00 | |||
| Volume | 769,533 | |||||
